913542-70-8

Basic information

• Product Name: di-tert-butyl 4-[2-(benzyloxy)-2-oxoethyl]-10-[2-(benzyloxy)-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate
• Synonyms: di-tert-butyl 4-[2-(benzyloxy)-2-oxoethyl]-10-[2-(benzyloxy)-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate
• CAS NO: 913542-70-8
• Molecular Weight: 668.831
• Mol File: 913542-70-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: di-tert-butyl 4-[2-(benzyloxy)-2-oxoethyl]-10-[2-(benzyloxy)-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: di-tert-butyl 4-[2-(benzyloxy)-2-oxoethyl]-10-[2-(benzyloxy)-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate(913542-70-8)
• EPA Substance Registry System: di-tert-butyl 4-[2-(benzyloxy)-2-oxoethyl]-10-[2-(benzyloxy)-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate(913542-70-8)

Safety Data

• Hazardous Substances Data: 913542-70-8(Hazardous Substances Data)

Upstream product

• 13139-12-3 tert-butyl 2,5-dioxopyrrolidin-1-yl carbonate 
• 294-90-6 1,4,7,10-tetraazacyclododecan 
• 5437-45-6 Benzyl bromoacetate 
• 913542-69-5 di-tert-butyl-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylate 

Downstream Products

• 871544-37-5 (7-Benzyloxycarbonylmethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetic acid benzyl ester 

Relevant articles and documents

RADIOPHARMACEUTICALS FOR DIAGNOSING AND TREATING CANCER

PROBLEM TO BE SOLVED: To provide CA-IX targeted, low-molecular weight pharmaceuticals that exhibit high specificity and fast clearance and are available in diagnosing and treating cancer and also applicable to theranostics of cancer. SOLUTION: The inventi

DIAGNOSTIC AGENT FOR INFECTIOUS DISEASES

A diagnostic agent for infectious diseases which is capable of distinguishing among different kinds of bacterial species and which allows simple and non-invasive measurement and/or imaging in a short period of time is provided; and a screening method for a therapeutic agent for infectious diseases caused by microorganisms are provided. A diagnostic agent for infectious diseases caused by nitroimidazole susceptible microorganisms, containing an imidazole derivative or a fused imidazole derivative having at least one nitro group on an imidazole ring, or a labeled form thereof as an active ingredient is provided.

Highly regioselective N-trans symmetrical diprotection of cyclen

A high yielding N-trans diprotection procedure for cyclen has been developed by using succinimide carbamate derivates of Boc and Cbz and chloroformate protecting groups.